Bio-Rad Laboratories Inc (BIO)
Return on total capital
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | -2,293,571 | -956,118 | -1,729,293 | 1,150,832 | 759,821 | 437,738 | 429,915 | 444,027 | 475,106 | 473,461 | 536,890 | 541,359 | 516,205 | 577,393 | 531,783 | 476,068 | 435,445 | 315,572 | 266,784 | 258,099 |
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 6,569,300 | 7,487,860 | 6,778,790 | 9,051,130 | 8,741,130 | 8,416,200 | 8,446,890 | 9,763,720 | 9,615,250 | 8,453,600 | 8,922,600 | 10,182,900 | 13,667,100 | 15,332,400 | 11,594,900 | 10,609,100 | 9,879,940 | 8,825,140 | 7,353,400 | 6,293,080 |
| Return on total capital | -34.91% | -12.77% | -25.51% | 12.71% | 8.69% | 5.20% | 5.09% | 4.55% | 4.94% | 5.60% | 6.02% | 5.32% | 3.78% | 3.77% | 4.59% | 4.49% | 4.41% | 3.58% | 3.63% | 4.10% |
December 31, 2024 calculation
Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $-2,293,571K ÷ ($—K + $6,569,300K)
= -34.91%
The return on total capital for Bio-Rad Laboratories Inc has shown fluctuations over the reported periods. From March 31, 2020, to June 30, 2021, the company's return on total capital remained relatively stable, hovering between 3.63% and 4.59%. However, there was a notable increase in the return on total capital to 6.02% by June 30, 2022.
Subsequently, the return on total capital started to decline, reaching 4.55% by March 31, 2023. There was a brief increase to 8.69% by December 31, 2023, but this was followed by a significant decrease to 12.71% by March 31, 2024. The return on total capital took a sharp downturn to -25.51% by June 30, 2024, which indicates a negative return on the company's total capital during that period.
The trend continued to deteriorate as the return on total capital fell even further to -34.91% by December 31, 2024. This negative trend in the return on total capital from June 30, 2024, to December 31, 2024, suggests challenges or issues affecting the company's capital utilization efficiency during this time. Further analysis would be needed to understand the factors contributing to this substantial decline in the return on total capital.
Peer comparison
Dec 31, 2024